TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Octapharma Nordic AB
Closing information (x1000 EUR)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
3,457,362
|
3,265,829
|
2,852,337 |
| Financial expenses |
8,767
|
1,824
|
3,361 |
| Earnings before taxes |
539,130
|
440,238
|
511,580 |
| EBITDA |
684,037
|
580,978
|
651,171 |
| Total assets |
4,936,922
|
4,432,764
|
4,233,220 |
| Current assets |
3,753,625
|
3,278,384
|
3,027,669 |
| Current liabilities |
476,480
|
415,632
|
398,994 |
| Equity capital |
4,245,826
|
3,830,665
|
3,619,099 |
| - share capital |
120
|
120
|
120 |
| Employees (average) |
10,501
|
10,587
|
9,734 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
86.0%
|
86.4%
|
85.5% |
| Turnover per employee |
329
|
308
|
293 |
| Profit as a percentage of turnover |
15.6%
|
13.5%
|
17.9% |
| Return on assets (ROA) |
11.1%
|
10.0%
|
12.2% |
| Current ratio |
787.8%
|
788.8%
|
758.8% |
| Return on equity (ROE) |
12.7%
|
11.5%
|
14.1% |
| Change turnover |
302,559
|
405,189
|
540,379 |
| Change turnover % |
10%
|
14%
|
23% |
| Chg. No. of employees |
-86
|
853
|
1,398 |
| Chg. No. of employees % |
-1%
|
9%
|
17% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.